Signals

NVD · CVE-2026-18907 · Path Traversal in Download File Feature in com.talpa.hibrowser 2.23.1.1 on Android allows arbitrary file write via directory traversal sequences in the filenameNVD · CVE-2026-18897 · 8.8 · A vulnerability was identified in UTT HiPER 1250GW up to v3.2.7-210907-180535. The impacted element is the function strcpy of the file /goform/getOneApConfTempENVD · CVE-2026-18896 · 6.3 · A vulnerability was determined in lavkush-maurya Student-Registration-System 1.0. The affected element is an unknown function of the file /student/changepass.phNVD · CVE-2026-18895 · 8.8 · A vulnerability was found in UTT HiPER 1250GW up to 3.2.7-210907-180535. Impacted is the function strcpy of the file /goform/APSecurity_5g. Performing a manipulCISA KEV · CVE-2026-18556 · 7.4 · N-able N-central Authentication Bypass Using an Alternate Path or Channel Vulnerability · Added 2026-08-04 · Due 2026-08-07CISA KEV · CVE-2026-34486 · 7.5 · Apache Tomcat Missing Encryption of Sensitive Data Vulnerability · Added 2026-08-04 · Due 2026-08-07NVD · CVE-2026-18907 · Path Traversal in Download File Feature in com.talpa.hibrowser 2.23.1.1 on Android allows arbitrary file write via directory traversal sequences in the filenameNVD · CVE-2026-18897 · 8.8 · A vulnerability was identified in UTT HiPER 1250GW up to v3.2.7-210907-180535. The impacted element is the function strcpy of the file /goform/getOneApConfTempENVD · CVE-2026-18896 · 6.3 · A vulnerability was determined in lavkush-maurya Student-Registration-System 1.0. The affected element is an unknown function of the file /student/changepass.phNVD · CVE-2026-18895 · 8.8 · A vulnerability was found in UTT HiPER 1250GW up to 3.2.7-210907-180535. Impacted is the function strcpy of the file /goform/APSecurity_5g. Performing a manipulCISA KEV · CVE-2026-18556 · 7.4 · N-able N-central Authentication Bypass Using an Alternate Path or Channel Vulnerability · Added 2026-08-04 · Due 2026-08-07CISA KEV · CVE-2026-34486 · 7.5 · Apache Tomcat Missing Encryption of Sensitive Data Vulnerability · Added 2026-08-04 · Due 2026-08-07

ClaimedMedium

Sydenham Laboratories

Healthcare · PH · 8base

All intelligence content is fictional, redacted and defensive. No real credentials, stolen data, exploit instructions, malware links, payment information or private personal data is published. Derived from public data-leak-site monitoring. Presented for defensive awareness only; unverified attacker claims.

Public preview

Public summary and status visible. Pro+ adds detailed defensive context and analysis.

Plans →

Public Summary

Actions

View pricing →

Full Summary

Sydenham Laboratories, Inc. (SLI) is an ISO 9001:2008, HACCP Certified, PIC/s GMP compliant pharmaceutical company that develops and manufactures healthcare products. SLI manufactures oral drug preparations in dosage forms of tablet, capsule, syrup, and powder for suspension. Non-penicillin, penicillin and cephalexin-based products are manufactured in separate buildings with 'clean room hepa-filtered' exclusive air-handling systems to ensure zero-cross contamination. SLI also manufactures food supplements in the above dosage forms. SLI is founded in 1971 by Dr. Eduardo R. dela Cruz, MD, a cardiologist and a former president of Philippine Medical Association. SLI derived its name from one of the great British physicians, Dr. Thomas Sydenham, known as the English Hippocrates, the founder of clinical medicine, and an advocate of effective management of illness that emphasized detailed observation and maintained patient recordshttp://www.sydenhamlab.com

Status

Claimed

Impact

Medium

Sector

Healthcare

Country